missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human ALY (aa 68-104) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (100%), Rat (100%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-84485 (PA5-84485. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
The protein encoded by this gene is a heat stable, nuclear protein and functions as a molecular chaperone. It is thought to regulate dimerization, DNA binding, and transcriptional activity of basic region-leucine zipper (bZIP) proteins.
Specifications
Specifications
| Accession Number | Q86V81 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 10189 |
| Name | Human ALY (aa 68-104) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | ally of AML-1 and LEF-1; ALY; ALY/REF; Aly/REF export factor; Aly/REF export factor L homeolog; aly/REF export factor-A; alyref; alyref.L; alyref-a; BEF; bZIP enhancing factor; bZIP-enhancing factor BEF; hypothetical protein LOC537706; REF; Ref1; REF1-I; Refbp1; RNA and export factor binding protein 1; RNA and export factor-binding protein 1; Tcra enhancer-binding factor interacting protein 1; THO complex 4; THO complex subunit 4; THO complex subunit 4-A; tho4; Tho4-A; THOC4; thoc4-a; transcriptional coactivator Aly/REF; XELAEV_18043750mg; zgc:171753 |
| Common Name | ALY |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction